Congressional Opposition to WISeR Model Demands Performance Data From CMS
A congressional coalition sent a letter on June 22 to Centers for Medicare and Medicaid Services (CMS) Administrator Mehmet Oz, M.D., expressing...
1 min read
Several medical organizations, including the College of American Pathologists and the American Medical Association, sent a letter to Centers for Medicare & Medicaid Services (CMS) Administrator Mehmet Oz, M.D., to express their collective concerns about the Merit-based Incentive Payment System (MIPS).
In the letter, the undersigned organizations point out the “urgent need for CMS to consider and accept more measures” into MIPS and specifically revive and promote the Qualified Clinical Data Registry (QCDR) option in accordance with the Medicare Access and CHIP Reauthorization Act of 2015.
CMS, in recent years, began to consolidate multiple cost measures into one composite, with the goal of minimizing physician burden. However, the letter states that these measures were never designed or tested as composites, and “the morass of reporting requirements and poorly designed programs” is what will exacerbate physician burden, rather than the number of MIPS Value Pathways. The letter goes on to urge CMS to consider what information might be lost if measure concepts are combined solely to reduce the number of measures in a particular program.
Source:
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://documents.cap.org/documents/2025-9-11_Sign_On_re_MIPS_Quality_Measures.pdf?_gl=1*u6jyzr*_ga*NTAyNDM3ODcwLjE3NDg4NjYzMjg.*_ga_97ZFJSQQ0X*czE3NTkxNjY0NzIkbzI0JGcxJHQxNzU5MTY2NzYzJGo2MCRsMCRoMA
Final Month of PAMA Reporting: Is Your Lab Ready?
July marks the final month of the 2026 PAMA reporting period. Laboratories that meet the definition of an applicable laboratory, which most do, have...
Humana Claims Payment Policies
Effective July 1, 2026, Humana will charge a $5.00 administrative fee for Medicare Advantage paper claim submissions.